| SHIM CLINIC 168 Bedok South Avenue 3 #01-473 Singapore 460168  Tel: (+65) 6100 7446 Fax: (+65) 6449 7446 24hr Answering Tel: (+65) 6333 5550 Web: www.ShimClinic.com | Opening Hours Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm Saturday & Sunday: 7 pm to 11 pm Public Holidays: Closed Last registration: half hour before closing time. Walk-in clinic. Appointments not required. Bring NRIC, Work Pass or Passport for registration. |
- Shim Clinic
- Travel Health
- Procedures
- Conditions
- Drugs & products
Vaccines | Shim Clinic, Singapore
SummaryVaccines | Shim Clinic, Singapore: clinic, Singapore. Private and confidential service. Definitions, references, and latest news.
Description
Vaccine types available for vaccination / immunisation (uk) / immunization (us) :
| Vaccine | Against | Disease | Age | D o s e s | Dose schedule | Price per dose (SG$) |
|---|---|---|---|---|---|---|
| Live attenuated | ||||||
| MMR vaccine | ≥12m | 1 | $70/= | |||
| Measles virus | Measles | |||||
| Mumps virus | Mumps | |||||
| Rubella virus | Rubella | |||||
| Varilrix™ | Varicella zoster virus HHV-3 | Varicella Chickenpox | 12m-12y | 1 | $121/= | |
| ≥13y | 2 | 6-10w interval | ||||
| Zostavax™ | Herpes zoster Shingles | ≥50y | 1 | $400/= | ||
| Stamaril® | Yellow fever virus | Yellow fever | 9m-59y | 1 | 10 yearly | $250/= |
| Inactivated / Whole / Viral & Bacterial | ||||||
| Ixiaro® | Japanese encephalitis virus | Japanese encephalitis | ≥17y | 2 | 2nd: 28d after 1st | $386/= |
| 1 | Booster: 12-24m after 2nd | |||||
| Dukoral® | Vibrio cholerae | Cholera | 2-6y | 3 | 1-6w interval | $113/= |
| 1 | Booster: 6m after 3rd | |||||
| ≥6y | 2 | 1-6w interval | ||||
| 1 | Booster: 2y after 2nd | |||||
| Inactivated / Fractional / Protein | ||||||
| Intanza™ | Influenza virus | Influenza | 18-59y | 1 | 1 yearly | $30/= |
| Fluarix™ | Influenza virus | Influenza | 6-36m | ½ | 1 yearly | $30/= |
| >3y | 1 | |||||
| Tetavax | Clostridium tetani | Tetanus | adults | 3 | 1-2m interval 3rd @ 6-12m after 2nd | $30/= |
| booster | 1 | 10 yearly | ||||
| Boostrix® | ≥4y | 1 | <10 yearly | $70/= | ||
| Corynebacterium diphtheriae | Diphtheria | |||||
| Clostridium tetani | Tetanus | |||||
| Bordetella pertussis | Pertussis Whooping cough | |||||
| Inactivated / Fractional / Polysaccharide / Pure | ||||||
| Typhim Vi® | Salmonella typhi | Typhoid fever | >5y | 1 | 3 yearly | $40/= |
| Mencevax® ACWY | Neisseria meningitidis types A, C, W-135 and Y | Meningococcal meningitis | >2y | 1 | $80/= | |
| Inactivated / Fractional / Polysaccharide / Conjugate | ||||||
| Menactra® | Neisseria meningitidis types A, C, W-135 and Y | Meningococcal meningitis | 2-55y | 1 | $220/= | |
| Prevenar 13® (SG) / Prevnar 13® (US) | Streptococcus pneumoniae types 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F | Pneumococcal infection | 6w-6m | 4 | 1m interval 4th @ 12-15m | $274/= |
| 7-11m | 2 | 1m interval | ||||
| 12-23m | 2 | 2m interval | ||||
| 2-5y | 1 | |||||
| ≥50y | 1 | |||||
If the clinic attendance is just for vaccination alone, no additional consultation fees are charged.
Testing for immunity against the following is available:
| Virus | Antibody Test | Price |
|---|---|---|
| Varicella zoster virus | Varicella Zoster IgG Antibody | $44/= |
| Rubella virus | Rubella IgG Antibody | $24/= |
| Hepatitis A virus | Hepatitis A IgG Antibody | $30/= |
| Hepatitis B virus | Hepatitis B surface Antibody | $10/= |
Other vaccines not stocked
- Haemophilus influenzae type b Vaccine / HIB Vaccine
- Polio Vaccine
- Rotavirus Vaccine
- Tuberculosis Vaccine / TB Vaccine / BCG Vaccine
- Rabies Vaccine
- Tick-Borne Encephalitis Vaccine / TBE Vaccine
- Live attenuated
- Viral: measles, mumps, rubella, varicella, yellow fever, oral polio.
- Bacterial: BCG.
- Inactivated
- Whole
- Viral: hepatitis A, Japanese encephalitis, rabies.
- Bacterial: cholera.
- Fractional
- Protein-Based
- Toxoid: diphtheria, tetanus,
- Subunit:
- Protein isolation: pertussis, influenza,
- Recombinant: hepatitis B, human papillomavirus,
- Polysaccharide-Based
- Protein-Based
- Whole
- Hajj and Umrah Health Requirements
- Memish ZA. The Hajj: communicable and non-communicable health hazards and current guidance for pilgrims. Euro Surveill. 2010;15(39)
- Memish Z.A., Goubeaud A., Broker M., Malerczyk C., Shibl A.M. Invasive meningococcal disease and travel. J Infect Public Health. 2010;3(4):143-151.
| Vaccine | Against | Disease | Age | D o s e s | Dose schedule | Price per dose (SG$) |
|---|---|---|---|---|---|---|
| Havrix™ 1440 Adult | Hepatitis A virus | Hepatitis A | ≥19y | 2 | m 0 & 6-12 | $90/= |
| Twinrix® | Hepatitis A virus Hepatitis B virus | Hepatitis A Hepatitis B | 1-15y | 2 | m 0, 6-12 | $120/= |
| ≥16y | 3 | m 0, 1, 6 | ||||
| 4 | d 0, 7, 21 & m 12 | |||||
| Inactivated / Fractional / Protein / Subunit / Recombinant | ||||||
| Engerix™-B 20 μg | Hepatitis B virus | Hepatitis B | 11-15y | 2 | m 0, & 6 | $50/= |
| ≥20y | 3 | m 0, 1, & 6 | ||||
| 4 | m 0, 1, 2, & 12 or d 0, 7, 21 & m 12 | |||||
| Gardasil® | HPV types 6, 11, 16, & 18 | Genital warts Cervical cancer | 9-26y | 3 | m 0, 2, & 6 or m 0, 1, & 4 | $195/= |
| Cervarix® | HPV types 16, & 18 (31, 33, & 45) | 10-25y | 3 | m 0, 1, & 6 m 0, 1, & 5 m 0, 2½, 12 | $195/= | |
| V503 | HPV types 6, 11, 16, 18, 31, 33, 45, 52, & 58 | 3 | m 0, 2, & 6 or m 0, 1, & 4 | $???/= | ||
Vaccine schedule / vaccination schedule / immunisation schedule / immunization schedule :
Annex A
For persons aged 0 to <18 years
| Vaccination against | Birth | 1 month | 3 months | 4 months | 5 months | 6 months | 12 months | 15 months | 18 months | 6-7 years^ | 10-11 years^^ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tuberculosis | BCG | ||||||||||
| Hepatitis B | HepB (D1) | HepB (D2) | HepB (D3)# | ||||||||
| Diphtheria, Tetanus, Pertussis | DTaP (D1) | DTaP (D2) | DTaP (D3) | DTaP (B1) | Tdap (B2) | ||||||
| Poliovirus | OPV (D1) | OPV (D2) | OPV (D3) | OPV (B1) | OPV (B2) | OPV (B3) | |||||
| Measles, Mumps, Rubella | MMR (D1) | MMR (D2)## | |||||||||
| Pneumococcal Disease | PCV (D1) | PCV (D2) | PCV (B1) | ||||||||
| Human Papillomavirus | Recommended for females 9 to 26 years; three doses are required at intervals of 0, 2, 6 months | ||||||||||
| Influenza | Recommended annually for all children aged 6 months to <5 years and children aged 6 months to <18 years in high-risk groups | ||||||||||
|
|
References:
- National Childhood and Adolescent Immunisation Schedule, Singapore For persons aged 0 to <18 years
- Infectious Diseases (Diphtheria and Measles Vaccination) Regulations
- Hepatitis B vaccine
- Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccine: Boostrix®
- MMR (measles, mumps, and rubella) vaccine
- PCV (pneumococcal conjugate vaccine): Prevenar 13®
- HPV (human papillomavirus) vaccine: Gardasil® & Cervarix®
- Influenza vaccine
- Vaccines images
- Vaccines - Wikipedia, the free encyclopedia
- Vaccines: Definition from Answers.com
- Vaccines - definition of Vaccines in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia.
- WHO | Vaccines
- Vaccines: HOME page for Vaccines and Immunizations site
Latest News
Study Again Finds Narcolepsy Risk With H1N1 Flu Vaccine Study Again Finds Narcolepsy Risk With H1N1 Flu Vaccine
Fri, 01 Mar 2013 16:39:24 +0100 | Medscape Today Headlines
A study from England finds an increased risk for narcolepsy in children who received adjuvanted pandemic H1N1 2009 flu vaccine, consistent with findings from Finland and Sweden. Medscape Medical News (Source: Medscape Today Headlines)
Composition of Hemagglutinin and Neuraminidase Affects the Antigen Yield of Influenza A(H1N1)pdm09 Candidate Vaccine Viruses.
Fri, 01 Mar 2013 11:30:02 +0100 | Japanese Journal of Infectious Diseases
In this study, we showed that the balance between HA and NA in the influenza A(H1N1)pdm09 virus affects its protein and antigen yield.
Effects of Simultaneous Immunization of Haemophilus influenzae Type b Conjugate Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine on Anti-Tetanus Potencies in Mice, Guinea Pigs, and Rats.
Fri, 01 Mar 2013 11:30:02 +0100 | Japanese Journal of Infectious Diseases
In this study, we investigated the effect of HibT containing combination vaccines on anti-tetanus potencies by using animal models (mouse, guinea pig, and rat). HibT vaccine and HibT components of imported DTaP-HibT vaccine alone showed comparable or higher anti-tetanus potency than DTaP vaccine and DTaP-containing components of combination vaccines. Mixing these components before injection resulted in potencies greater than the sum of individual potencies. Injecting individual components at separate sites in animals resulted in potency roughly equivalent to the sum of the individual potencies. These results provide useful information regarding the use of HibT-containing multivalent vaccines in childhood immunization.
Prevalence and Risk Factors of Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children in Japan.
Fri, 01 Mar 2013 11:30:02 +0100 | Japanese Journal of Infectious Diseases
Authors: Ueno M, Ishii Y, Tateda K, Anahara Y, Ebata A, Iida M, Inamura S, Takahata K, Suzuki Y, Chang B, Wada A, Sugita M, Tanaka T, Nishiwaki Y
Relationship between Virus-Neutralizing Antibody Levels and the Number of Rabies Vaccinations: a Prospective Study of Dogs in Japan.
Fri, 01 Mar 2013 11:30:02 +0100 | Japanese Journal of Infectious Diseases
Authors: Watanabe I, Yamada K, Aso A, Suda O, Matsumoto T, Yahiro T, Ahmed K, Nishizono A
Grp170 Shows Potential As A "Cancer Vaccine"
Fri, 01 Mar 2013 09:00:00 +0100 | Health News from Medical News Today
Preclinical, laboratory studies suggest a novel immunotherapy could potentially work like a vaccine against metastatic cancers, according to scientists at Virginia Commonwealth University Massey Cancer Center. Results from a recent study show the therapy could treat metastatic cancers and be used in combination with current cancer therapies while helping to prevent the development of new metastatic tumors and train specialized immune system cells to guard against cancer relapse... (Source: Health News from Medical News Today)
European Medicines Agency Recommends Approval Of Hexyon 6-In-1 Paediatric Vaccine
Fri, 01 Mar 2013 09:00:00 +0100 | Health News from Medical News Today
Upon approval Hexyon will be the only fully liquid, ready-to-use 6-in-1 paediatric vaccine in Europe Sanofi Pasteur MSD, the joint venture between MSD and Sanofi Pasteur in Europe, announced today that their innovative 6-in-1 paediatric vaccine Hexyon has been recommended for marketing authorisation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP)... (Source: Health News from Medical News Today)
Aiming For Vaccine For All Meningitis Strains
Fri, 01 Mar 2013 08:00:00 +0100 | Health News from Medical News Today
Scientists at the University of Southampton have taken a significant and important step in keeping people safe from the most common form of meningitis in the UK. Meningitis B (also known as Meningococcal group B or MenB) is one of the deadliest strains of meningitis. Each year, an average of 1,870 people in the UK are affected by the disease with one in 10 people dying from it... (Source: Health News from Medical News Today)
Potential Cancer Drugs From Naturally Occurring Compounds
Fri, 01 Mar 2013 08:00:00 +0100 | Health News from Medical News Today
Inspired by a chemical that fungi secrete to defend their territory, MIT chemists have synthesized and tested several dozen compounds that may hold promise as potential cancer drugs. A few years ago, MIT researchers led by associate professor of chemistry Mohammad Movassaghi became the first to chemically synthesize 11,11'-dideoxyverticillin, a highly complex fungal compound that has shown anti-cancer activity in previous studies... (Source: Health News from Medical News Today)
Sudan: Third Phase of Yellow Fever Vaccination Campaign to Begin in West Darfur
Fri, 01 Mar 2013 04:34:59 +0100 | AllAfrica News: Health and Medicine
[Radio Dabanga]El-Geneina -The health minister of West Darfur announced that the third phase of the vaccination campaign against yellow fever that reportedly killed 171 people across Darfur would be launched next Tuesday in the state. (Source: AllAfrica News: Health and Medicine)
ABOUT TRUST ONLINE |
| Singapore Web Design by Zeus Micro | Copyrighted Material: Not for Reproduction or Distribution - Vaccines | Shim Clinic, Singapore |